The observation that EGFR inhibitors are significantly enriched and more effective in HNSCC compared to other non-HNSCC is consistent with the observation that EGFR gene dependency is also selectively enriched among HNSCC [Fig. S4A]. Here, EGFR is linked to head and neck squamous cell carcinoma.